Title: | Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study |
Authors: | Adachi, Yasushi Browse this author |
Nojima, Masanori Browse this author |
Mori, Mitsuru Browse this author →KAKEN DB |
Yamashita, Kentaro Browse this author |
Yamano, Hiro-o Browse this author |
Nakase, Hiroshi Browse this author |
Endo, Takao Browse this author |
Wakai, Kenji Browse this author →KAKEN DB |
Sakata, Kiyomi Browse this author →KAKEN DB |
Tamakoshi, Akiko Browse this author →KAKEN DB |
Keywords: | Esophageal cancer |
Insulin-like growth factor |
Insulin-like growth factor binding protein |
Nested case-control study |
Odds ratio |
Issue Date: | 21-May-2017 |
Publisher: | Baishideng Publishing Group |
Journal Title: | World Journal of Gastroenterology |
Volume: | 23 |
Issue: | 19 |
Start Page: | 3488 |
End Page: | 3495 |
Publisher DOI: | 10.3748/wjg.v23.i19.3488 |
Abstract: | AIM: To assess the relationship between serum levels of insulin-like growth factor-1 (IGF1)/IGF-binding protein-3 (IGFBP3) and the risk of esophageal carcinoma. METHODS: We assessed the relationship between the serum levels of these molecules and the risk of esophageal cancer in a prospective, nested case-control study of participants from the Japan Collaborative Cohort Study. A baseline survey was conducted from 1988 to 1990. Of the 110585 enrolled participants, 35% donated blood samples. Those who had been diagnosed with esophageal cancer were considered cases for nested case-control studies. A conditional logistic model was used to estimate odds ratios for the incidence of esophageal cancer associated with serum IGF1 and IGFBP3 levels. RESULTS: Thirty-one cases and 86 controls were eligible for the present assessment. The molar ratio of IGF1/IGFBP3, which represents the free and active form of IGF1, was not correlated with the risk of esophageal carcinoma. A higher molar difference between IGFBP3 and IGF1, which estimates the free form of IGFBP3, was associated with a decreased risk of esophageal carcinoma (P = 0.0146), and people in the highest tertile had the lowest risk (OR = 0.107, 95% CI: 0.017-0.669). After adjustment for body mass index, tobacco use, and alcohol intake, the molar difference of IGFBP3-IGF1 was inversely correlated with the risk of esophageal carcinoma (P = 0.0150). CONCLUSION: The free form of IGFBP3, which is estimated by this molar difference, may be inversely associated with esophageal cancer incidence. |
Rights: | http://creativecommons.org/ licenses/by-nc/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/66888 |
Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|